Constance Weisner1,2, Cynthia I Campbell1,2, Andrea Altschuler1, Bobbi Jo H Yarborough3, Gwen T Lapham4, Ingrid A Binswanger5,6, Rulin C Hechter7, Brian K Ahmedani8, Irina V Haller9, Stacy A Sterling1, Dennis McCarty10, Derek D Satre1, Andrea H Kline-Simon1. 1. Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. 2. Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, California, USA. 3. Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA. 4. Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 5. Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA. 6. Colorado Permanente Medical Group, Aurora, Colorado, USA. 7. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. 8. Center for Health Policy & Health Services Research and Behavioral Health Services, Henry Ford Health System, Detroit, Michigan, USA. 9. Essentia Institute of Rural Health, Essentia Health, Duluth, Minnesota, USA. 10. Oregon Health Sciences University Portland, Oregon, USA.
Abstract
Background: Only 10% of patients with alcohol and other drug (AOD) disorders receive treatment. The AOD Initiation and Engagement in Treatment (AOD-IET) measure was added to the national Healthcare Effectiveness Data and Information Set (HEDIS) to improve access to care. This study identifies factors related to improving AOD-IET rates. Methods: We include data from 7 health systems with differing geographic, patient demographic, and organizational characteristics; all used a common Virtual Data Warehouse containing electronic health records and insurance claims data. Multilevel logistic regression models examined AOD-IET among adults (18+). Results: A total of 86,565 patients had an AOD diagnosis qualifying for the HEDIS denominator. Initiation rates varied from 26% to 46%; engagement rates varied from 14% to 29%. Women versus men (odds ratio [OR] = 0.81, 95% confidence interval [CI] = 0.76-0.86); Hispanics (OR = 0.85, 95% CI = 0.79-0.91), black/African Americans (OR = 0.82, 95% CI = 0.75-0.90), and Asian Americans (OR = 0.83, 95% CI = 0.72-0.95) versus whites; and patients aged 65+ versus 18-29 (OR = 0.82, 95% CI = 0.74-0.90) had lower odds of initiation. Patients aged 30-49 versus 18-29 (OR = 1.11, 95% CI = 1.04-1.19) and those with prior psychiatric (OR = 1.26, 95% CI = 1.18-1.35) and medical (OR = 1.18, 95% CI = 1.10-1.26) conditions had higher odds of engagement. Identification in primary care versus other departments was related to lower odds of initiation (emergency department [ED]: OR = 1.55, 95% CI = 1.45-1.66; psychiatry/AOD treatment: OR = 3.58, 95% CI = 3.33-3.84; other outpatient: OR = 1.19, 95% CI = 1.06-1.32). Patients aged 30-49 versus 18-29 had higher odds of engagement (OR = 1.26, 95% CI = 1.10-1.43). Patients aged 65+ versus 18-29 (OR = 0.51, 95% CI = 0.43-0.62) and black/African Americans versus whites (OR = 0.64, 95% CI = 0.53-0.77) had lower odds. Those initiating treatment in psychiatry/AOD treatment versus primary care (OR = 7.02, 95% CI = 5.93-8.31) had higher odds of engagement; those in inpatient (OR = 0.40, 95% CI = 0.32-0.50) or other outpatient (OR = 0.73, 95% CI = 0.59-0.91) settings had lower odds. Discussion: Rates of initiation and engagement varied but were low. Findings identified age, race/ethnicity, co-occurring conditions, and department of identification as key factors associated with AOD-IET. Focusing on these could help programs develop interventions that facilitate AOD-IET for those less likely to receive care.
Background: Only 10% of patients with alcohol and other drug (AOD) disorders receive treatment. The AOD Initiation and Engagement in Treatment (AOD-IET) measure was added to the national Healthcare Effectiveness Data and Information Set (HEDIS) to improve access to care. This study identifies factors related to improving AOD-IET rates. Methods: We include data from 7 health systems with differing geographic, patient demographic, and organizational characteristics; all used a common Virtual Data Warehouse containing electronic health records and insurance claims data. Multilevel logistic regression models examined AOD-IET among adults (18+). Results: A total of 86,565 patients had an AOD diagnosis qualifying for the HEDIS denominator. Initiation rates varied from 26% to 46%; engagement rates varied from 14% to 29%. Women versus men (odds ratio [OR] = 0.81, 95% confidence interval [CI] = 0.76-0.86); Hispanics (OR = 0.85, 95% CI = 0.79-0.91), black/African Americans (OR = 0.82, 95% CI = 0.75-0.90), and Asian Americans (OR = 0.83, 95% CI = 0.72-0.95) versus whites; and patients aged 65+ versus 18-29 (OR = 0.82, 95% CI = 0.74-0.90) had lower odds of initiation. Patients aged 30-49 versus 18-29 (OR = 1.11, 95% CI = 1.04-1.19) and those with prior psychiatric (OR = 1.26, 95% CI = 1.18-1.35) and medical (OR = 1.18, 95% CI = 1.10-1.26) conditions had higher odds of engagement. Identification in primary care versus other departments was related to lower odds of initiation (emergency department [ED]: OR = 1.55, 95% CI = 1.45-1.66; psychiatry/AOD treatment: OR = 3.58, 95% CI = 3.33-3.84; other outpatient: OR = 1.19, 95% CI = 1.06-1.32). Patients aged 30-49 versus 18-29 had higher odds of engagement (OR = 1.26, 95% CI = 1.10-1.43). Patients aged 65+ versus 18-29 (OR = 0.51, 95% CI = 0.43-0.62) and black/African Americans versus whites (OR = 0.64, 95% CI = 0.53-0.77) had lower odds. Those initiating treatment in psychiatry/AOD treatment versus primary care (OR = 7.02, 95% CI = 5.93-8.31) had higher odds of engagement; those in inpatient (OR = 0.40, 95% CI = 0.32-0.50) or other outpatient (OR = 0.73, 95% CI = 0.59-0.91) settings had lower odds. Discussion: Rates of initiation and engagement varied but were low. Findings identified age, race/ethnicity, co-occurring conditions, and department of identification as key factors associated with AOD-IET. Focusing on these could help programs develop interventions that facilitate AOD-IET for those less likely to receive care.
Authors: Joseph V Selby; Julie A Schmittdiel; Janelle Lee; Vicki Fung; Sean Thomas; Nancy Smider; Francis J Crosson; John Hsu; Bruce Fireman Journal: Med Care Date: 2010-02 Impact factor: 2.983
Authors: Bobbi Jo H Yarborough; Felicia W Chi; Carla A Green; Agatha Hinman; Jennifer Mertens; Arne Beck; Michael Horberg; Constance Weisner; Cynthia I Campbell Journal: J Addict Med Date: 2018 Jul/Aug Impact factor: 3.702
Authors: Mary E Charlson; Robert E Charlson; Janey C Peterson; Spyridon S Marinopoulos; William M Briggs; James P Hollenberg Journal: J Clin Epidemiol Date: 2008-07-10 Impact factor: 6.437
Authors: Rachel Sayko Adams; Deborah W Garnick; Alex H S Harris; Elizabeth L Merrick; Keith Hofmann; Wendy Funk; Thomas V Williams; Mary Jo Larson Journal: J Subst Abuse Treat Date: 2020-05-07
Authors: Thibaut Davy-Mendez; Varada Sarovar; Tory Levine-Hall; Alexandra N Lea; Stacy A Sterling; Felicia W Chi; Vanessa A Palzes; Kendall J Bryant; Constance M Weisner; Michael J Silverberg; Derek D Satre Journal: Drug Alcohol Depend Date: 2021-09-28 Impact factor: 4.492
Authors: Andrea H Kline-Simon; Scott P Stumbo; Cynthia I Campbell; Ingrid A Binswanger; Constance Weisner; Irina V Haller; Rulin C Hechter; Brian K Ahmedani; Gwen T Lapham; Amy M Loree; Stacy A Sterling; Bobbi Jo H Yarborough Journal: Subst Abus Date: 2019-01-31 Impact factor: 3.716
Authors: Amy M Loree; Hsueh-Han Yeh; Derek D Satre; Andrea H Kline-Simon; Bobbi Jo H Yarborough; Irina V Haller; Cynthia I Campbell; Gwen T Lapham; Rulin C Hechter; Ingrid A Binswanger; Constance Weisner; Brian K Ahmedani Journal: Subst Abus Date: 2019-01-25 Impact factor: 3.716
Authors: Rulin C Hechter; Michael A Horberg; Constance Weisner; Cynthia I Campbell; Richard Contreras; Lie-Hong Chen; Bobbi Jo H Yarborough; Gwen T Lapham; Irina V Haller; Brian K Ahmedani; Ingrid A Binswanger; Andrea H Kline-Simon; Derek D Satre Journal: Subst Abus Date: 2019-03-25 Impact factor: 3.716
Authors: Cynthia I Campbell; Constance Weisner; Ingrid A Binswanger; Gwen T Lapham; Brian K Ahmedani; Bobbi Jo H Yarborough; Irina V Haller; Andrea Altschuler; Rulin C Hechter; Amy M Loree; Andrea H Kline-Simon Journal: Subst Abus Date: 2019-01-24 Impact factor: 3.716
Authors: Vanessa A Palzes; Constance Weisner; Felicia W Chi; Andrea H Kline-Simon; Derek D Satre; Matthew E Hirschtritt; Murtuza Ghadiali; Stacy Sterling Journal: JMIR Med Inform Date: 2020-07-22